Clinical trial · Interventional
Tai Chi Easy in Treating Cancer Survivors With Peripheral Sensory Neuropathy
Pilot Study of Effects of Tai Chi Easy on Cancer Survivors Experiencing Neuropathy
NCT01980368CI-TRIAL-00032031withdrawnN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): No participants enrolled-slow accrual
Summary
Brief summary (as posted)
This pilot clinical trial studies how well Tai Chi Easy works in treating cancer survivors with peripheral sensory neuropathy. Tai Chi Easy is a simple and repetitive form of exercise that consists of movements with meditation and may improve peripheral neuropathy symptoms among cancer survivors.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Survivor | — | UNRESOLVED | — |
| Peripheral Sensory Neuropathy | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Educational Intervention | Other | — | UNRESOLVED |
| Exercise Intervention | Behavioral | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group I (Tai Chi Easy)
- description
- Patients attend Tai Chi Easy class for 60 minutes once a week for 6 weeks. Patients also receive a DVD and exercise manual of Tai Chi Easy exercises and are encouraged to practice at home for 30 minutes most days per week for 6 weeks.
- interventionNames
- Behavioral: Exercise Intervention
- Other: Questionnaire Administration
- type
- ACTIVE_COMPARATOR
- label
- Group II (educational control)
- description
- Patients receive readings each week and attend a book club to discuss the readings for 60 minutes once a week for 6 weeks.
- interventionNames
- Other: Educational Intervention
- Other: Questionnaire Administration
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 1 month - 5 years following completion of cytotoxic chemotherapy treatment for any cancer, and are experiencing neuropathy * Self-report of \>= 4 on the Peripheral Neuropathy Question Exclusion Criteria: * Recurrence of cancer or other active cancer * Severe cachexia, dizziness, bone pain, or severe nausea (as judged by the investigator) * Uncontrolled diabetes, untreated hypothyroidism
References
Publications (0)
Data not yet available
No reference posted for this study.